Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Scientists just reversed Alzheimer's symptoms in mice using nanoparticles, and the approach is genuinely clever.
Most treatments try to break up the toxic protein plaques that build up in Alzheimer's brains.
This one ignores the plaques and fixes the system that's supposed to clear them in the first place.
Your brain has a built-in waste disposal pathway.
A protein called LRP1 grabs toxic amyloid-beta and escorts it out through the blood-brain barrier into the bloodstream.
In Alzheimer's, that pathway gets clogged. Waste piles up. Neurons suffer.
The nanoparticles mimic LRP1.
They hitch a ride on a transport route the brain already uses, slip through the barrier, and kickstart the whole clearance process back into action.
They don't just clear the backlog either. They seem to restart the system so the brain keeps cleaning itself.
3 doses. Within an hour, toxic protein levels dropped 50-60%. Elderly mice were behaving like healthy young ones months later.
Now, mouse studies fail in humans constantly, and Alzheimer's research has an especially brutal track record.
But working WITH the brain's own biology rather than trying to overpower it feels like a fundamentally smarter angle.
Worth keeping an eye on.